SBN 0.00% 0.0¢ sun biomedical limited

long term hlders vs traders, page-3

  1. 2,209 Posts.
    Hi brown,

    Good post and you have put your view across well but im going to beg to differ on a couple of fronts.
    You intamated that some of us on here have all of sudden said we were long term holders after the bad news but i think you will find if you check the posts of myself, vin gsw, scilly and others that we have all stated we were long on this well before the fda setback.
    secondly imo i think the co quoted 12 months for fda to cover themselves until they meet with them.
    also i dont believe the co put all there resources into fda otherwise the 25 year china deal wouldnt have eventuated.
    And yes they havent tied up deal with chinese govt yet but i dont think a chinese distributor would sign a long term deal where they are spending the cash by mid this year without good reason.
    Agree with that advances stages of deals are taking to long but to intermate that they have fallen thru and they company hasnt told us is wrong and to me just trying to make an inflamorty remark.
    why do you think they would have done that when they didnt even try to sugar coat the fda setback.
    really (and im not sure of this) they probably could have just told us that the fda required more info/testing
    I agree as others have posted they can definetly improve on communication and finalising deals (but other forces can contribute to delays). but i disagree with 12 months and fda being the be all and end all of this co.(even oraline for that matter).

    if that was the case i wouldnt be still holding.
    i do agree that it may take a while for sbn to come back, but i dont think it will be 12 months and as someone else says on here expect the unexpected.
    im gathering you no longer hold but look forward to when you buy back in sometime down the track whenever that maybe.

 
watchlist Created with Sketch. Add SBN (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.